AOC3 and diabetic kidney disease: ASP8232 is a small molecule Vascular Adhesion Protein-1 (VAP-1) inhibitor that demonstrated an albuminuria lowering effect in a Phase 2 trial in diabetic kidney disease (DKD) patients (ALBUM study) [3].